News

Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIO™ (pexidartinib) as the first and only treatment for adult patients with symptomatic TGCT associated with severe morbidity or functional limitations and not amenable to improvement with surgery. TGCT is...

Amicus Therapeutics announced that the Agency of Medicines, Food and Medical Devices (ANMAT) in Argentina has granted approval for the first-in-class, oral small molecule pharmacological chaperone Galafold® (migalastat), as a monotherapy for the treatment of people aged 16 years...

Amicus Therapeutics  announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research Institute (AWRI) at Nationwide Children’s Hospital. AWRI is conducting the ongoing Phase 1/2 clinical study of a single one-time...

GlycoMimetics, Inc. reported that Pfizer Inc. announced that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal study did not meet its primary or key secondary efficacy endpoints. The objective of the trial was to...

LexaGene Holdings, Inc, a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers, announced that it has been recognized by the Centers for Disease Control and Prevention (CDC) and the FDA Antibiotic Resistance (AR) Isolate...

United Cargo announced an enhancement to its specialized service for pharmaceuticals, healthcare material and other commodities requiring temperature-sensitive transport. Through an interline agreement with all-cargo carrier AeroUnion, widebody TempControl service is now available to Mexico City International Airport (MEX). TempControl...

Signant Health (formerly CRF Health and Bracket) announces that its Senior Vice President, Dr. David Daniel, has been selected by PharmaVOICE as one of the top 100 most inspiring people within the life sciences sector. Dr. Daniel was selected...